SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-025094
Filing Date
2022-11-14
Accepted
2022-11-14 17:25:40
Documents
84
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q sabs-20220930.htm   iXBRL 10-Q 3158669
2 EX-31.1 sabs-ex31_1.htm EX-31.1 31776
3 EX-31.2 sabs-ex31_2.htm EX-31.2 31779
4 EX-32.1 sabs-ex32_1.htm EX-32.1 13741
5 EX-32.2 sabs-ex32_2.htm EX-32.2 14207
  Complete submission text file 0000950170-22-025094.txt   11377031

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT sabs-20220930_cal.xml EX-101.CAL 59059
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT sabs-20220930_lab.xml EX-101.LAB 570690
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sabs-20220930_pre.xml EX-101.PRE 443063
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT sabs-20220930_def.xml EX-101.DEF 306780
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sabs-20220930.xsd EX-101.SCH 71670
78 EXTRACTED XBRL INSTANCE DOCUMENT sabs-20220930_htm.xml XML 2154325
Mailing Address 2100 EAST 54TH STREET NORTH SIOUX FALLS SD 57104
Business Address 2100 EAST 54TH STREET NORTH SIOUX FALLS SD 57104 605-679-6980
SAB Biotherapeutics, Inc. (Filer) CIK: 0001833214 (see all company filings)

IRS No.: 853899721 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39871 | Film No.: 221387965
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences